Works matching IS 17528054 AND DT 2024 AND VI 17 AND IP 11


Results: 24
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    A randomized, placebo‐controlled first‐in‐human study of oral TQS‐168 in healthy volunteers: Assessment of safety, tolerability, pharmacokinetics, pharmacodynamics, and food effect.

    Published in:
    CTS: Clinical & Translational Science, 2024, v. 17, n. 11, p. 1, doi. 10.1111/cts.70064
    By:
    • Hannestad, Jonas;
    • Smith, Steven;
    • Lam, Andrew;
    • Hurt, Janet;
    • Harada, Nicole;
    • Kim, Richard;
    • Das, Abhirup;
    • Brunello, Juliana;
    • Whitaker, Gareth;
    • Chalmers, David;
    • Senjoti, Faria;
    • Lin, Wu;
    • Coghill, James;
    • Bansal, Yogesh;
    • Sidhu, Sharan;
    • Zann, Vanessa;
    • Liu, Enchi
    Publication type:
    Article
    16
    17

    Clinical pharmacokinetics and pharmacodynamics of ongericimab: A potential long‐acting PCSK9 monoclonal antibody in healthy subjects and patients with hypercholesterolemia: Randomized, double‐blind, placebo‐controlled phase Ia and Ib/II studies

    Published in:
    CTS: Clinical & Translational Science, 2024, v. 17, n. 11, p. 1, doi. 10.1111/cts.70061
    By:
    • Jiang, Juanjuan;
    • Xu, Li;
    • Chai, Lin;
    • Guan, Xiaoyuan;
    • Zhang, Li;
    • Liu, Hong;
    • Yan, Yan;
    • Li, Lili;
    • Zhao, Yi;
    • Bai, Xuelian;
    • Tian, Lei;
    • Jia, Youhong
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24

    Issue Information.

    Published in:
    CTS: Clinical & Translational Science, 2024, v. 17, n. 11, p. 1, doi. 10.1111/cts.13342
    Publication type:
    Article